Resources

Research

Policy

Policy work of the Council and other organizations aimed at improving aspirin use

Other Resources by Type

Fact Sheets

Calculators

  • Coronary Heart Disease Risk Calculator
  • Stroke Calculator
  • Is Aspirin Right for Me? Questionnaire

Case Study

Webinar Presentation

  • ACPM Aspirin and Disease Prevention: A Clinical Perspective (60:02, Archived Webinar)
    This program addressing the appropriate use of aspirin for the prevention of vascular diseases and cancer included 3 speakers on 3 topics. Craig Williams, PharmD, BCPS, FNLA, Oregon Health and Science University spoke about Aspirin and Secondary Prevention. Randall Stafford, MD, PhD, FACPM, Stanford University presented on Aspirin and Primary Prevention. Andrew Chan, MD, MPH, Harvard Medical School presented Aspirin and Cancer. Presented December 3, 2014.

Advertisements

Videos

  • Why Consider Aspirin for Cancer Prevention? (5:10, Vimeo)
    A presentation from Andrew T. Chan, MD, MPH, Associate Professor, Department of Medicine, Harvard Medical School, 2013
  • Who Should Take Aspirin? Finding the Right Balance (6:54, Vimeo)
    A Question and Answer session with Randall S. Stafford, MD, PHD, Professor of Medicine, Stanford Prevention Research Center, Stanford University
  • What Is the Aspirin Project? (1:21, YouTube)
    An overview of information available on the Aspirin Project website (no audio)
  • Dr. David Agus on Why Aspirin Is the “Real Health Reform” (CBS This Morning, 2016)
    Includes article in text.
  • Aspirin Advocate vs. Skeptic: Any Common Ground? (15:15, requires Flash Player)
    Paul Ridker, a cardiologist at the Brigham and Women's Hospital in Boston and the Harvard Medical School, and John Cleland from the Imperial College and the Royal Brompton Hospital in London discuss aspirin. They divide the “aspirin controversy” into: unstable angina and acute coronary ischemia; secondary prevention; and primary prevention. Transcript also available.
  • Cardiology Conundrum: Aspirin for Primary Prevention (9:20, requires Flash Player)
    Sharon L. Mulvagh, MD, director of the Women's Heart Clinic at Mayo Clinic and Dr. Francisco Lopez, director of preventive cardiology at Mayo Clinic discussaspirin and primary prevention and how “FDA Shuts the Door on Aspirin in Primary Prevention.” Transcript also available.
  • Continue Aspirin in Endoscopy Patients? A Resounding “Yes” (7:09, requires Flash Player)
    Dr. David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia hosts GI Common Concerns—Computer Consult and commentates on “Reconsidering Aspirin and Endoscopy.” Transcript also available.

Slide Deck

A References page is available on this website.